Tusitala: William Ramirez
Aso O Foafoaga: 18 Setema 2021
Faafouga Aso: 14 Novema 2024
Anonim
NMN & RESVERATROL– WHAT TO LOOK FOR? | Dr David Sinclair Interview Clips
Ata: NMN & RESVERATROL– WHAT TO LOOK FOR? | Dr David Sinclair Interview Clips

Anotusi

Resveratrol o se vailaʻau o loʻo maua i mumu uaina, paʻu mumu vine, sua o le vine viole, mulberry, ma i aofaʻi laʻititi i pinati. E faʻaaogaina e fai ma vailaʻau.

Resveratrol e masani ona faʻaaogaina mo maualuga suka, kanesa, fatu fatu, ma le tele o isi tulaga. Peitai, e leai se malosi faʻamaoniga e lagolagoina le faʻaaogaina o resveratrol mo nei faʻaaogaina.

Natura Faʻafomaʻi Maea Faʻamatalaga fua faatatau aoga faʻavae i luga o faʻasaienitisi faʻamaoniga e tusa ma le fua faʻatatau lenei: Aoga, Masalo Lelei Lelei, E Lelei Lelei, Masalo Lelei Lelei, Masalo Lelei, Le Lelei, ma Le lava Faʻamaoniga e Fuafua ai.

Le aoga togi mo RESVERATROL e faapea:

Masalo e aoga mo ...

  • Fiva vao. O le faʻaaogaina o le nasal spray o loʻo iai le resveratrol faʻatolu taimi i aso uma mo le 4 vaiaso e foliga mai e faʻaititia ai le aliali o faʻamaʻi o tagata matutua o loʻo vaʻai ile vaitau. O le faʻaaogaina o le nasal spray o loʻo iai le resveratrol ma le beta-glucans faʻatolu taimi i aso uma mo le 2 masina e foliga mai e faʻaititia ai le aliali o faʻamaʻi o tamaiti e iai vaitau o gasegase.
  • Puta tele. O nisi suʻesuʻega faʻaalia ai o le faʻaaogaina o le resveratrol e mafai ona faʻateleina ai le paʻu o pauna i tagata matutua lapopoʻa.

Masalo le aoga mo ...

  • Maʻi fatu. Tagata e 'aʻai maualuga aofaʻiga o dietary resveratrol e foliga mai e leai se maualalo le aʻafia o faʻamaʻi fatu pe a faʻatusatusa i tagata e faʻaumatia aofaʻi maualalo. E le gata i lea, o le faʻaaogaina o le resveratrol e le gutu e foliga mai e le faʻaleleia ai le maualuga o le toto poʻo gaʻo toto ua taʻua o triglycerides i tagata e ono aʻafia i maʻi fatu.
  • O se faʻavasegaina o faʻailoga e faʻateleina ai le aʻafia o le maʻisuka, maʻi fatu, ma le papala (metabolic syndrome). O le inuina o le resveratrol e foliga mai e le faʻaititia ai le toto, suka i le toto, poʻo le cholesterol i tagata e maua i le metabolic syndrome. O suʻesuʻega muamua e faʻaalia ai ole resveratrol e ono fesoasoani e faʻaititia le mamafa o le tino ma le gaʻo o le tino i tagata e maua i le metabolic syndrome. Ae sili atu suʻesuʻega e manaʻomia e faʻamaonia ai.
  • Fausia le gaʻo i le ate i tagata e inu laʻititi pe leai foi se ava malosi (e le o le ava malosi gaʻo i le ate poʻo le NAFLD). O le tele o suʻesuʻega vave o loʻo faʻaalia ai o le resveratrol e le faʻaleleia le gaioiga ole ate, maʻila le maʻila, poʻo le maualuga ole koluse i tagata e iai le NAFLD.

Le lava molimau e fuaina aoga mo ...

  • Fuafua. O suʻesuʻega amata o loʻo faʻaalia ai o le faʻaaogaina o le gel o loʻo iai le resveratrol i foliga mo le 60 aso e faʻaititia ai le ogaoga o fuafua.
  • Faʻaleaʻoga i mea e manatua ma mafaufauga e masani ona tupu i le matua. E le malamalama pe a fai o le resveratrol e fesoasoani i le manatuaina poʻo le mafaufau mafaufauga i tagata matutua. O nisi o suʻesuʻega amata e faʻaalia ai o le resveratrol atonu e faʻaleleia atili le mafaufau ma mafaufau i fafine pe a maeʻa le menopause. Ae o isi suʻesuʻega faʻaalia ai o le resveratrol na tuʻuina atu i maualuga paʻu pe mo se taimi umi e le faʻaleleia atili ai le manatuaina poʻo le mafaufau mafaufauga i soifua maloloina tagata matutua.
  • O le faʻamaʻi toto e faʻaititia ai le maualuga o le polotini i le toto ua taʻua o le hemoglobin (beta-thalassemia). I le amataga o suʻesuʻega, o le inuina o le trans-resveratrol e le faʻaleleia ai le maualuga o le hemoglobin poʻo le manaʻoga mo le tuiina o le toto i tagata e maua i le beta-thalassemia.
  • Kanesa. Tagata e 'aʻai maualuga aofaʻiga o dietary resveratrol e foliga mai e leai se maualalo lamatiaga o le kanesa faʻatusatusa i tagata e' aʻai maualalo aofaiga.
  • Maʻi suka. O nisi suʻesuʻega faʻaalia ai o le resveratrol e faʻaleleia ai le puleaina o suka i le toto i tagata e maua ile maʻi suka. Ae o isi suʻesuʻega faʻaalia leai se aoga. Resveratrol ono fesoasoani e tuʻu i lalo le suka i le toto i naʻo tagata gasegase e maualuga le suka i le toto. E manaʻomia nisi suʻesuʻega e faʻamaonia ai.
  • Faʻaleagaina fatugaʻo i tagata e maua ile maʻisuka (suka suka). I le amataga o suʻesuʻega, o le faʻaaogaina o le resveratrol ma le vailaʻau o le losartan e mafai ona faʻaleleia atili ai nisi o faʻatamaiga o fatugaʻo i tagata e maua i le suka suka.
  • O se faʻamaʻi papala e faigata ai ona manava (faʻalavelave faʻafuaseʻi papala poʻo le COPD). O suʻesuʻega muamua e taʻu mai ai o le aveina o se oloa tuʻufaʻatasi o loʻo iai le resveratrol, vitamini C, zinc, ma le flavonoids e faʻaititia ai le tale ma gaʻo i totonu o tagata i le COPD. Ae le o mautinoa pe o le penefiti e mafua mai i le resveratrol poʻo isi mea.
  • Osteoarthritis. I le amataga o suʻesuʻega o loʻo faʻaalia ai o le faʻaopoopoina o le resveratrol i togafitiga masani mo tulivae osteoarthritis e ono faʻaleleia ai le tiga, gaioiga ma le maʻaʻa nai lo togafitiga masani naʻo oe.
  • Faʻaleleia le faʻafomaʻi e taʻua ole peritoneal dialysis. O suʻesuʻega muamua na faʻaalia ai o le resveratrol atonu e faʻavavevave ai le faʻamamaina o le toto i tagata o loʻo faʻataʻamiloina i le toto peritoneal.
  • O le faʻamaʻi o le hormonal lea e mafua ai le faʻateleina o ovaries ma sista (polycystic ovary syndrome poʻo le PCOS). O suʻesuʻega muamua na faʻaalia ai o le resveratrol e faʻaititia ai le testosterone i fafine e iai le PCOS. Ae e le faʻaleleia le mamafa, maualuga o le lipid, fuafua, pe le manaʻomia le tuputupu aʻe o fafine i lenei tulaga.
  • Rheumatoid gugu (RA). Avea resveratrol faʻatasi ma vailaʻau mo RA foliga mai e faʻaititia ai le numera o tiga ma fulafula soʻoga. Ae leiloa pe a fai ole resveratrol e fesoasoani foʻi e faʻaititia le soʻoga faʻaleagaina.
  • O se ituaiga o faʻamaʻi manava manava (ulcerative colitis). O le vave suʻesuʻe faʻaalia ai resveratrol ono faaleleia ai auga ma faʻaititia ai le gaioiga o ulcerative colitis.
  • Paʻu matua.
  • Faʻaleaʻoga i le manatuaina ma mafaufauga mafaufau i tagata matutua e sili atu nai lo le mea masani mo latou tausaga.
  • Faʻaʻaʻa o alatoto (atherosclerosis).
  • Manatua ma mafaufauga mafaufauga (mafaufau faʻatino galuega).
  • Isi tulaga.
E tele molimau e manaʻomia e fua ai le resveratrol mo nei faʻaaogaina.

Resveratrol ono faʻalauteleina alatoto toto ma faʻaititia le gaioiga o sela taua i le faʻaputuputuga toto. O nisi suʻesuʻega faʻapea mai o le resveratrol e vaivai le estrogen (o le fafine hormone) aʻafiaga. E ono faʻaititia foʻi le tiga ma le fulafula (pupuga). Resveratrol ono faʻaititia le maualuga o suka (kulukose) i le toto ma fesoasoani i le tino e tau faasaga i faʻamaʻi. E ono mafai foi ona puipuia polotini i le faiʻai mai le pipii faʻatasi e fesoasoani e puipuia faʻamaʻi pei o le Alzheimer's disease.

A ave e le gutu: Resveratrol o MAFAI ONA SAFIA pe a faʻaaogaina i aofaʻi o loʻo maua i meaʻai. A ave i tui e oʻo atu i le 1500 mg i aso uma e oʻo atu i le 3 masina, o le resveratrol e MAFAI ONA SAFIA. Maualuga tui oʻo i le 2000-3000 mg i aso uma na faʻaaoga saogalemu mo 2-6 masina. Peitai, o nei maualuga tui o resveratrol e ono mafua ai faʻafitauli manava.

A faʻapipiʻi i le paʻu: Resveratrol o MAFAI ONA SAFIA pe a faʻaoga i le paʻu e oʻo atu i le 30 aso.

Lapataiga faʻapitoa & lapataʻiga:

Maitaga ma susu-fafagaina: Resveratrol o MAFAI ONA SAFIA pe a faʻaaogaina i aofaʻi maua i nisi o meaʻai. Peitai, i le taimi o maitaga ma susu-fafagaina, o le mafuaʻaga o resveratrol e taua. Resveratrol o loʻo maua i paʻu vine, sua o le vine, uaina, ma isi mea taumafa. Uaina e le tatau ona faʻaaogaina o se puna o resveratrol i taimi o maʻito ma susu-fafagaina.

Tamaiti: Resveratrol o MAFAI ONA SAFIA i tamaiti pe a faʻapipiʻi i pupuʻuisu ona oʻo atu i le 2 masina.

Faamai toto: Resveratrol ono faʻatelegese le faʻaputuputu o le toto ma faʻateleina le ono iai o le toto i tagata e maua ile faʻamaʻi toto.

Hormone-sensitive tulaga e pei o le kanesa o le susu, uterine kanesa, ovarian kanesa, endometriosis, po o uterine fibroids: Resveratrol ono pei o le estrogen. Afai e i ai ni ou tulaga e ono atili ai ona leaga e ala i le aafia i le estrogen, aua le faʻaaogaina resveratrol.

Taotoga: Resveratrol ono faʻatuputeleina le aʻafia o le toto i le taimi ma pe a uma le taotoga. Taofi le toe faʻaaogaina o le resveratrol a itiiti mai 2 vaiaso ae leʻi faia se taotoga faʻatulagaina.

Feololo
Faʻaeteete i lenei tuʻufaʻatasiga.
O vailaʻau na suia e le ate (Cytochrome P450 1A1 (CYP1A1) substrates)
Nisi vailaʻau e suia ma talepeina i lalo e le ate. Resveratrol ono faʻaititia le vave ona gagau e le ate nisi vailaʻau. I le teori, o le inuina o le resveratrol faʻatasi ai ma isi vailaʻau e malepe i lalo e le ate e ono faʻateleina ai aʻafiaga ma aʻafiaga o nisi vailaʻau.

O ni vailaʻau na suia e le ate e aofia ai le chlorzoxazone, theophylline, ma le bufuralol.
O vailaʻau na suia e le ate (Cytochrome P450 1A2 (CYP1A2) substrates)
Nisi vailaʻau e suia ma talepeina i lalo e le ate. Resveratrol ono faʻaititia le vave ona gagau e le ate nisi vailaʻau. I le teori, o le inuina o le resveratrol faʻatasi ai ma isi vailaʻau e malepe i lalo e le ate e ono faʻateleina ai aʻafiaga ma aʻafiaga o nisi vailaʻau.

O ni vailaʻau na suia e le ate e aofia ai le clozapine (Clozaril), cyclobenzaprine (Flexeril), fluvoxamine (Luvox), haloperidol (Haldol), imipramine (Tofranil), mexiletine (Mexitil), olanzapine (Zyprexa), pentazocine (Talwin), propranol ), tacrine (Cognex), zileuton (Zyflo), zolmitriptan (Zomig), ma isi.
O vailaʻau na suia e le ate (Cytochrome P450 1B1 (CYP1B1) substrates)
Nisi vailaʻau e suia ma talepeina i lalo e le ate. Resveratrol ono faʻaititia le vave ona gagau e le ate nisi vailaʻau. I le teori, o le inuina o le resveratrol faʻatasi ai ma isi vailaʻau e malepe i lalo e le ate e ono faʻateleina ai aʻafiaga ma aʻafiaga o nisi vailaʻau.

O ni vailaʻau na suia e le ate e aofia ai le theopylline, omeprazole, clozapine, progesterone, lansoprazole, flutamide, oxaliplatin, erlotinib, ma le caffeine.
O vailaʻau na suia e le ate (Cytochrome P450 2C19 (CYP2C19) substrates)
Nisi vailaʻau e suia ma talepeina i lalo e le ate. Resveratrol ono faʻaititia le vave ona gagau e le ate nisi vailaʻau. I le teori, o le inuina o le resveratrol faʻatasi ai ma isi vailaʻau e malepe i lalo e le ate e ono faʻateleina ai aʻafiaga ma aʻafiaga o nisi vailaʻau.

O nisi vailaʻau na suia e le ate e aofia ai le amitriptyline (Elavil), carisoprodol (Soma), citalopram (Celexa), diazepam (Valium), lansoprazole (Prevacid), omeprazole (Prilosec), phenytoin (Dilantin), warfarin, ma le tele o isi.
O vailaʻau na suia e le ate (Cytochrome P450 2E1 (CYP2E1) substrates)
Nisi vailaʻau e suia ma talepeina i lalo e le ate. Resveratrol ono faʻaititia le vave ona gagau e le ate nisi vailaʻau. I le teori, o le inuina o le resveratrol faʻatasi ai ma isi vailaʻau e malepe i lalo e le ate e ono faʻateleina ai aʻafiaga ma aʻafiaga o nisi vailaʻau.

O nisi vailaʻau na suia e le ate e aofia ai le acetaminophen, chlorzoxazone (Parafon Forte), ethanol, theophylline, ma vailaʻau faʻapipiʻi pei o le enflurane (Ethrane), halothane (Fluothane), isoflurane (Forane), methoxyflurane (Penthrane).
O vailaʻau na suia e le ate (Cytochrome P450 3A4 (CYP3A4) substrates)
Nisi vailaʻau e suia ma talepeina i lalo e le ate. Resveratrol ono faʻaititia le vave ona gagau e le ate nisi vailaʻau. I le teori, o le inuina o le resveratrol faʻatasi ai ma isi vailaʻau e malepe i lalo e le ate e ono faʻateleina ai aʻafiaga ma aʻafiaga o nisi vailaʻau. Peitaʻi, o ni suʻesuʻega vave na faʻaalia ai feteʻenaʻi iʻuga.

Nisi vailaʻau suia e le ate aofia ai nisi kalisiu blockers poloka (diltiazem, nicardipine, verapamil), chemotherapeutic sooupu (etoposide, paclitaxel, vinblastine, vincristine, vindesine), antifungals (ketoconazole, itraconazole), glucocorticoids, alfentanuls (Alfenta) ), fentanyl (Sublimaze), tutupocaine (Xylocaine), losartan (Cozaar), fexofenadine (Allegra), midazolam (Versed), ma isi.
Vailaau e faʻagesegese le faʻaputuputu o le toto (Anticoagulant / Antiplatelet vailaʻau)
Resveratrol ono faʻatelegese le tolo o le toto. O le inuina o le resveratrol faʻatasi ai ma vailaʻau e mafai ai foi ona faʻatelegese le faʻaputuga o fale e ono faʻatuputeleina ai le avanoa o le totolia ma le palapala.

O vailaʻau e faʻatelegese ai le tui ole toto e iai le aspirin, clopidogrel (Plavix), diclofenac (Voltaren, Cataflam, ma isi), ibuprofen (Advil, Motrin, isi), naproxen (Anaprox, Naprosyn, ma isi), dalteparin (Fragmin), enoxaparin (Lovenox) , heparin, warfarin (Coumadin), ma isi.
Laʻau ma mea faʻaopopo e ono faʻatelegese ai le faʻaputuputu o le toto (Anticoagulant / Antiplatelet herbs and supplement)
Resveratrol ono faʻatelegese le tolo o le toto. O le faʻaaogaina faʻatasi ma isi vailaʻau poʻo ni vailaʻau faʻaopopo e ono faʻatelegese ai le tuiina o le toto e ono faʻatuputeleina ai le ono maua o le toto pe gagau i nisi tagata. O nei vailaʻau aofia ai angelica, clove, danshen, feverfew, kaliki, ginger, ginkgo, ginseng Panax, solofanua chestnut, lanumumu mumu, turmeric, ma isi.
Gaʻo ma meaʻai lololo
O le aveina o le resveratrol ma se taumafataga e maualuga ai le gaʻo e ono faʻaititia ai le aofaʻi o le resveratrol e mitiia e le tino.
O vailaʻau nei sa suʻesuʻeina i suʻesuʻega faasaienisi.

MATUTUA

E SAUNIU:
  • Mo vaitau faʻaletonu (vao fever): Lua faʻasusu o le 0.1% resveratrol nasal spray i totonu o isu taʻitasi tolu taimi / aso mo le oʻo atu i le 4 vaiaso.
  • Mo lapoʻa: 500 mg pe laʻititi ifo le resveratrol i aso uma mo 3 masina pe sili atu.
3,5,4 'TriHydroxy-Transstibene, (E) - 5- (4-hydroxystyryl) benzene-1,3-diol, 3,4', 5-stilbenetriol, 3,5,4 '-trihydroxystilbene, 3,4 ', 5-trihydroxystilbene, 3,5,4'-trihydroxy-trans-stilbene, Cis-Resveratrol, Extrait de Vin, Extrait de Vin Rouge, Kojo-Kon, Phytoalexin, Phytoalexine, Phytoestrogen, Phyto-œstrogène, Pilule de Vin, Protykin, Red Wine Extract, Resvératrol, Resveratrols, Resvératrols, RSV, RSVL, Stilbene Phytoalexin, Trans-Resveratrol, Trans-Resvératrol, Wine Extract, Wine Pill.

Ina ia aoao atili e uiga i le auala na tusia ai lenei tusitusiga, faʻamolemole vaʻai i le Natura Faʻafomaʻi Maea Faʻamatalaga metotia


  1. Zhang N, Liang T, Jin Q, Shen C, Zhang Y, Jing P. Chinese yam (Dioscorea contradita Thunb.) Faʻamalieina le manava o le manava e fesoʻotaʻi ma vailaʻau, suia le microbiota o le manava, ma faʻateleina le maualuga o gaʻo pupuʻu gaʻo i isumu. Meaʻai Res Int 2019; 122: 191-198. Vaʻai faʻamatala.
  2. Akbari M, Tamtaji OR, Lankarani KB, et al. Aʻafiaga o resveratrol faʻaopoopoga luga endothelial gaioiga ma le toto faʻamalosi i tagata mamaʻi ma metabolic syndrome ma faʻafitauli faʻaletonu: o se iloiloga faʻavasega ma meta-suʻesuʻega o randomized pulea faʻataʻitaʻiga. Maualuga o le toto Press Cardiovasc Prev 2019; 26: 305-19. Vaʻai faʻamatala.
  3. Köbe T, Witte AV, Schnelle A, et al. Aʻafiaga o le resveratrol i le puleaina o le kulukose, hippocampal fausaga ma fesoʻotaʻiga, ma manatuaina gaioiga i tagata mamaʻi ma le vaivai le mafaufau mafaufau. Luma Neurosci 2017; 11: 105. Vaʻai faʻamatala.
  4. Witte AV, Kerti L, Margulies DS, Flöel A. Aafiaga o le resveratrol i le manatuaina o gaioiga, fesoʻotaʻiga galue o le hippocampal, ma le suka i le soifua maloloina o tagata matutua. J Neurosci 2014; 34: 7862-70. Vaʻai faʻamatala.
  5. Mousavi SM, Milajerdi A, Sheikhi A, et al. O le faʻaopopoga Resveratrol e matuaʻi aʻafia ai fua o le lapopoa: o se faʻavasega lelei ma le tofo-tali faʻataʻitaʻiga ole faʻataʻitaʻia o faʻataʻitaʻia. Obes Rev 2019; 20: 487-98. Vaʻai faʻamatala.
  6. Sattarinezhad A, Roozbeh J, Shirazi Yeganeh B, Omrani GR, Shams M. Resveratrol faaitiitia le albuminuria i le suka suka Maʻi suka Metab 2019; 45: 53-9. Vaʻai faʻamatala.
  7. Zhang C, Yuan W, Fang J, Wang W, He P, Lei J, Wang C. Le lelei o le Resveratrol Faʻaopoopo e faʻasaga i le le-Alcoholic Fatty Liver Disease: O se Meta-Suʻesuʻega o Placebo-Faʻataʻitaʻia Fomaʻi Faʻataʻitaʻi. PLoS Tasi. 2016 Aug 25; 11: e0161792. Vaʻai faʻamatala.
  8. Poulsen MK, Nellemann B, Bibby BM, et al. Leai se aafiaga ole resveratrol ile VLDL-TG kinetics ma le inisula lagona i tamaloloa lapopoʻa e leai se ava malosi gaʻo ole gaʻo. Maʻisuka Obes Metab. 2018; 20: 2504-2509. Vaʻai faʻamatala.
  9. Hussain SA, Marouf BH, Ali ZS, Ahmmad RS. Malosiaga ma le saogalemu o le galulue faʻatasi o resveratrol ma meloxicam i tagata mamaʻi ma tulivae osteoarthritis: o se pailate faʻasolosolo suesuega. Togafitiga Interv Matutua. 2018; 13: 1621-1630. Vaʻai faʻamatala.
  10. Huhn S, Beyer F, Zhang R, et al. Aʻafiaga o le resveratrol i mea e manatua ai, faʻafesoʻotaʻi le hippocampus ma le microstructure i tagata matutua - O se faʻataʻitaʻiga faʻatonutonuina faʻataʻitaʻiina. Neuroimage 2018; 174: 177-190. Vaʻai faʻamatala.
  11. Haghpanah S, Zarei T, Eshghi P, et al. Malosiaga ma le saogalemu o resveratrol, o le oral hemoglobin F-augmenting sooupu, i tagata mamaʻi ma beta-thalassemia intermedia. Ann Hematol. 2018; 97: 1919-1924. Vaʻai faʻamatala.
  12. Anton SD, Ebner N, Dzierzewski JM, et al. Aʻafiaga o le 90 Aso o Resveratrol Faʻaopoopoga i luga o le Faagaioiga gaioiga i Toeaina: O se Pailate Suʻesuʻega. J Suʻesuʻega Faʻapitoa Med. 2018; 24: 725-732. Matamata i isi tusitusiga.
  13. Lv C, Zhang Y, Shen L. Muamua falemaʻi aoga iloiloga o resveratrol i tagata matutua ma le afaina i le rhinitis. Int Arch Allergy Immunol 2018; 175: 231-6. Vaʻai faʻamatala.
  14. Zortea K, Franco VC, Francesconi LP, Cereser KM, Lobato MI, Belmonte-de-Abreu PS. Resveratrol Faʻaopoopoga i Schizophrenia Patients: O le Randomized Clinical Trial Evaluating Serum Glucose ma Cardiovascular Risk Factors. Meaʻai. 2016; 8 73. Vaʻai faʻamatala.
  15. Wightman EL, Haskell-Ramsay CF, Reay JL, et al. O aʻafiaga o le faʻaauauina o le trans-resveratrol supplementation i vaega o le mafaufau faʻatinoina, lagona, moe, soifua maloloina ma le toto o le cerebral tafe i maloloina, talavou tagata. Br J Nutr. 2015; 114: 1427-37. Vaʻai faʻamatala.
  16. Turner RS, Thomas RG, Craft S, et al. O se faʻavasega, faʻalua-tauaso, placebo-pulea faʻataʻitaʻiga o resveratrol mo Alzheimer faamaʻi. Neurology 2015; 85: 1383-91. Vaʻai faʻamatala.
  17. Timmers S, de Ligt M, Phielix E, et al. Resveratrol as Add-on Therapy in Subjects With Well-Controll Type 2 Diabetes: O Se Faʻataʻitaʻiga Pulea Faʻataʻitaʻiina. Maʻi suka. 2016; 39: 2211-2217. Vaʻai faʻamatala.
  18. Samsami-Kor M, Daryani NE, Asl PR, Hekmatdoost A. Aneti-Faʻamataʻu Aʻafiaga o Resveratrol i Tagata Maʻi ma Ulcerative Colitis: O Se Faʻatusatusaga, Faʻalua-Tauaso, Placebo-pulea Pilot Suesuega. Arch Med Res. 2015; 46: 280-5. Vaʻai faʻamatala.
  19. Lin CT, Sun XY, Lin AX. Faʻaopopoga ma maualuga-inumaga trans-resveratrol faʻaleleia atili ultrafiltration i peritoneal dialysis tagata mamaʻi: o se lumanaʻi, faʻasolosolo, lua-tauaso suʻesuʻega. Ua le manuia Ren. 2016; 38: 214-21. Vaʻai faʻamatala.
  20. Kjaer TN, Ornstrup MJ, Poulsen MM, et al. Resveratrol faʻaititia le maualuga o le faʻasolosolo androgen muamua na muamua ae leai sona aʻafiaga i luga, testosterone, dihydrotestolone, PSA maualuga poʻo le tele prostate. O le 4 masina le faʻataʻitaʻi le faʻataʻitaʻiina i aliʻi e matutua tausaga. Faitoma. 2015; 75: 1255-63. Vaʻai faʻamatala.
  21. Evans HM, Howe PR, Wong RH. Aʻafiaga o Resveratrol i Cognitive Performance, Mood ma Cerebrovascular Faagaioiga i Post-Menopausal Fafine; O le 14-Vaiaso Faʻataʻitaʻiina Placebo-Faʻatonutonuina Faʻalavelave Faʻalavelave faʻalavelave. Meaʻai. 2017; 9. Vaʻai faʻamatala.
  22. Elgebaly A, Radwan IA, AboElnas MM, et al. Resveratrol Faʻaopoopoga i Tagata Maʻi ma Non-Alcoholic Fatty ate Faamaʻi: Faʻalapotopotoga Iloiloga ma Meta-auiliiliga. J Gastrointestin ate Dis. 2017; 26: 59-67.Vaʻai faʻamatala.
  23. Bo S, Ponzo V, Ciccone G, et al. Ono masina ole resveratrol supplementation e leai se aoga tele i ituaiga 2 tagata mamaʻi suka. O se faʻafitauli, lua faʻalua tauaso, placebo-pulea faʻataʻitaʻiga. Faletalavai Res. 2016; 111: 896-905. Vaʻai faʻamatala.
  24. Bedada SK, Neerati P. Resveratrol Pretreatment afaina ai CYP2E1 Gaoioiga o Chlorzoxazone i Soifua Maloloina Tagata ofo. Phytother Res. 2016; 30: 463-8. Vaʻai faʻamatala.
  25. Banaszewska B, Wrotynska-Barczynska J, Spaczynski RZ, Pawelczyk L, Duleba AJ. Aʻafiaga o Resveratrol i le Polycystic Ovary Syndrome: O le Faʻalua-tauaso, Faʻafesuiaʻi, Placebo-pulea Faʻamasinoga. J Clin Endocrinol Metab. 2016; 101: 4322-4328. Vaʻai faʻamatala.
  26. Khojah HM, Ahmed S, Abdel-Rahman MS, Elhakeim EH. Resveratrol o se lelei adjuvant togafitiga i le puleaina o le rheumatoid galu: o se falemaʻi suesue. Clin Rheumatol. 2018; [Epub luma o le lolomi]. Vaʻai faʻamatala.
  27. Shishodia S, Aggarwal BB. Resveratrol: o se polyphenol mo vaitau uma. Resveratrol i le soifua maloloina ma faʻamaʻi. Boca Raton, FL: CRC Press, 2005.
  28. Creasy LL, Kofe M. Phytoalexin gaosiaina gafatia o fua vine. J Am Soc Hortic Sci. 1988; 113: 230-234.
  29. Langcake P, McCarthy W. O le sootaga o le resveratrol gaosiga i siama o laʻau vine e Botrytis cinerea. Vitis 1979; 18: 244-253.
  30. Tau NL, Gomes AP, Ling AJ, Duarte FV, Martin-Montalvo A, North BJ, Agarwal B, Ye L, Ramadori G, Teodoro JS, Hubbard BP, Varela AT, Davis JG, Varamini B, Hafner A, Moaddel R, Rolo AP, Coppari R, Palmeira CM, de Cabo R, Baur JA, Sinclair DA. SIRT1 e manaʻomia mo le faʻagaoioia o le AMPK ma aoga aoga o le resveratrol i le mitochondrial function. Cellab Metab. 2012 Me 2; 15: 675-90. Vaʻai faʻamatala.
  31. Wang S, Moustaid-Moussa N, Chen L, Mo H, Shastri A, Su R, Bapat P, Kwun I, Shen CL. Faʻamatalaga fou o meaʻai polyphenols ma le lapoʻa. J Nutr Biochem. 2014 Ian; 25: 1-18. Vaʻai faʻamatala.
  32. Palamara AT, Nencioni L, Aquilano K, De Chiara G, Hernandez L, Cozzolino F, Ciriolo MR, Garaci E. Le taofiofia o le fulū O se siama na toe faia e le resveratrol. J Faamaʻi Dis. 2005 Me 15; 191: 1719-29. Vaʻai faʻamatala.
  33. Mastromarino P, Capobianco D, Cannata F, Nardis C, Mattia E, De Leo A, Restignoli R, Francioso A, Mosca L. Resveratrol taofia le toe faʻafouina o le rhinovirus ma le faʻaalia o mea feula i le nasal epithelia. Antiviral Res. 2015 Nov; 123: 15-21. Vaʻai faʻamatala.
  34. Crowell JA, Korytko PJ, Morrissey RL, Booth TD, Levine BS. Resveratrol-fesoʻotaʻiga oona fatugaʻo. Toxicol Sci. 2004 Tes; 82: 614-9. Vaʻai faʻamatala.
  35. Semba RD, Ferrucci L, Bartali B, Urpí-Sarda M, Zamora-Ros R, Sun K, Cherubini A, Bandinelli S, Andres-Lacueva C. Resveratrol maualuga ma mafuaʻaga uma mafuaʻaga feoti i tagata matutua o nonofo i tagata lautele. JAMA Intern Med. 2014 Iulai; 174: 1077-84. Vaʻai faʻamatala.
  36. Sahebkar A. Aʻafiaga o le resveratrol faʻaopoopoga i luga o le lipid plasma: o se faʻavasega iloiloga ma meta-auiliiliina o le faʻatonutonuina faʻataʻitaʻia o faʻataʻitaʻiga. Nutr Rev. 2013 Tes; 71: 822-35. Vaʻai faʻamatala.
  37. Miraglia Del Giudice M, Maiello N, Capristo C, Alterio E, Capasso M, Perrone L, Ciprandi G. Resveratrol plus carboxymethyl-ß-glucan e faʻaititia ai isu o le isu i tamaiti e maua i le pollen-induced rhinitis. Curr Med Resin Opin. 2014 Oketopa; 30: 1931-5. Vaʻai faʻamatala.
  38. Méndez-del Villar M, González-Ortiz M, Martínez-Abundis E, Pérez-Rubio KG, Lizárraga-Valdez R. Aafiaga o le resveratrol pulega i metabolic syndrome, inisula lagona, ma iniseti faʻamatalaga. Metab Syndr Relat Le mautonu. 2014 Tes; 12: 497-501. Vaʻai faʻamatala.
  39. Magyar K, Halmosi R, Palfi A, Feher G, Czopf L, Fulop A, Battyany I, Sumegi B, Toth K, Szabados E. Cardioprotection e le resveratrol: O le suʻesuʻega o le falemaʻi o tagata i tagata mamaʻi ua maua i le maʻi o le toto. Clin Hemorheol Microcirc. 2012; 50: 179-87. Vaʻai faʻamatala.
  40. Liu K, Zhou R, Wang B, Mi MT. Aʻafiaga o le resveratrol i luga ole kulukose faʻatonutonu ma le lagona o le inisalini: o le suʻesuʻeina ole suʻesuʻega o le 11 faʻasolosolo ona faʻataʻitaʻia na tofotofoga. Am J Clin Nutr. 2014 Iuni; 99: 1510-9. Vaʻai faʻamatala.
  41. Faghihzadeh F, Adibi P, Rafiei R, Hekmatdoost A. Resveratrol supplementation e faʻalauteleina ai le faʻamalolosi o le biomarkers i tagata mamaʻi e leai se ava malosi i le ate. Nutr Res. 2014 Oketopa; 34: 837-43. Vaʻai faʻamatala.
  42. Chachay VS, Macdonald GA, Martin JH, Whitehead JP, O'Moore-Sullivan TM, Lee P, Franklin M, Klein K, Taylor PJ, Ferguson M, Coombes JS, Thomas GP, Cowin GJ, Kirkpatrick CM, Prins JB, Hickman IJ. Resveratrol e le faʻamanuiaina tagata mamaʻi e le o le ava malosi gaʻo i le ate. Clin Gastroenterol Hepatol. 2014 Tes; 12: 2092-103.e1-6. Vaʻai faʻamatala.
  43. Hudson, GM, Shelmadine, B., Cooke, M., Genovese, J., Greenwood, M., ma Willoughby, DS Resveratrol Faʻaopoopoga Ma Suiga I Glucose, Insulin, Ma mRNA Faʻamatalaga Mulimuli Faʻamalositino I Tamaitai Ova ova: 2467. Vailaau & Saienisi i Taʻaloga & Faʻamalositino 2011; 43
  44. Guarnieri, R., Pappacoda, A., ma Solitro, S. [O le resveratrol o loʻo i ai le vailaʻau e faʻaititia ai le faʻaletonu o le oxidative ma faʻaleleia atili ai faʻailoga o le falemaʻi i mataupu o le COPD] . Cochrane Tutotonu Tusi Resitala o Faʻataʻitaʻiga Faʻataʻitaʻiga 2009;
  45. Yoon, SJ, Cho, KS, Lee, YH, Kim, DS, ma Hong, SJ RESVERATROL INHIBITS CXCR4 MEDIATED TUMOR GROWTH AND MIGRATION OF HUMAN KIDNEY CANCER CELL I VITRO MA I VIVO: 428. Tusi o Urology 2009; 181: 153- 154.
  46. Klink, JC, Poulton, S., Antonelli, J., Potter, MQ, Jayachandran, J., Tewari, AK, Febbo, PG, Pizzo, SV, ma Freedland, S. RESVERATROL ALTERS PROSTATE CANCER XENOGRAFT GROWTH: 724. Journal o Urology 2009; 181
  47. Seely, K. A. Cannabinoid receptor inverse agonists as novel novel therapeutic agents. "Le Saienisi ma Inisinia. O Saienisi ma Inisinia 2009; 70 (4-B)
  48. Pregliasco, F. ma Cogo, R. [Antioxidant ma le puipuia o vailaʻau i tagata matutua o loʻo faia tui puipui o le fulū taimi e faʻaleleia atili ai le tali atu a le mafaufau ma faʻaititia ai vaega o manava manava] Lʻuso di sostanze antiossidanti ed immunomodulanti in una popolazione anziana so. Cochrane Tutotonu Resitara o Faʻataʻitaʻiga Faʻataʻitaʻiga 2010;
  49. Steigerwald, M. D., Fisk, M. Z., Smoliga, J. M., ma Rundell, K. W. Aafiaga o le Resveratrol I luga o le Faʻamalosi o le oxidative Ma le galueina o le vaskina i le maeʻa ai o le faʻamalositino i le faʻamaʻimauina o le ea: 2645. Faʻafomaʻi ma Saienisi i Taʻaloga & Faʻamalositino 2011; 43
  50. Beli, J., Smoliga, JM, Bost, KM, ma Maroon, JC Tolu Masina Faʻapitoa Faʻamatalaga o se Tasi Polokalame Faʻafefiloi Faʻaleleia Faʻaletino ma Neurocognitive Faʻailoilo Faʻataʻitaʻiga i Sedentary Matutua: 2205. Faʻafomaʻi ma Saienisi i Taʻaloga & Faʻamalositino 2008; 40: S246 .
  51. Grujic Milanovic, J., Mihailovic-Stanojevic, N., Miloradovic, Z., Jacevic, V., Milosavljevic, I., Milanovic, S., Ivanov, M., ma Jovovic, DJ RESVERATROL O LE FAʻAFOEGA O LE TOTONU, SUIGA O ANTIOXIDANT GAOIOIGA FAʻAMATALAGA MA FUAFUAGA FAʻAMATALAGA I FAʻAALIGA FAʻAALIGA O MALIGNAN HYPERTENSION PP.29.171. Tusi o tala o le toto maualuga 2010; 28
  52. Pendurthi, U. R., Williams, J. T., ma Rao, L. V. Resveratrol, o se polyphenolic compound o lo o maua i le uaina, o loʻo taofia ai le faʻamatalaina o vaega o sela i sela sela: O se mea e mafai ai mo penefiti o le fatu e fesoʻotaʻi ma le feʻaveaʻi o le taumafaina o le uaina. Arterioscler.Thromb.Vasc.Biol 1999; 19: 419-426. Vaʻai faʻamatala.
  53. Rotondo, S., Rajtar, G., Manarini, S., Celardo, A., Rotillo, D., de Gaetano, G., Evangelista, V., ma Cerletti, C. Aafiaga o trans-resveratrol, o se natura polyphenolic lotoa, i luga ole tagata polymorphonuclear leukocyte gaioiga. Br.J.Farmacol. 1998; 123: 1691-1699. Vaʻai faʻamatala.
  54. Bhatt, J. K., Thomas, S., ma Nanjan, M. J. Resveratrol supplementation faaleleia le glycemic control i le ituaiga 2 suka mellitus. Nutr.Res. 2012; 32: 537-541. Vaʻai faʻamatala.
  55. Hector, K. L., Lagisz, M., ma Nakagawa, S. O le aʻafiaga o le resveratrol i le umi o le ola i luga o ituaiga: o le meta-analysis. Biol.Lett. 10-23-2012; 8: 790-793. Vaʻai faʻamatala.
  56. Roehr, B. Cardiovascular tagata suʻesuʻe na latou gaosia faʻamatalaga i suʻesuʻega o le uaina mumu. BMJ 2012; 344: e406. Vaʻai faʻamatala.
  57. Crandall, J. P., Oram, V., Trandafirescu, G., Reid, M., Kishore, P., Hawkins, M., Cohen, H. W., ma Barzilai, N. Pilot suʻesuʻega o resveratrol i tagata matutua matutua ma le faʻaletonu o le glucose tolerance. J.Gerontol.A Biol.Sci.Med.Sci. 2012; 67: 1307-1312. Vaʻai faʻamatala.
  58. Fujitaka, K., Otani, H., Jo, F., Jo, H., Nomura, E., Iwasaki, M., Nishikawa, M., Iwasaka, T., ma Das, DK Faʻafou resveratrol Longevinex faaleleia endothelial gaioiga i tagata matutua ma metabolic syndrome mauaina masani togafitiga. Nutr.Res 2011; 31: 842-847. Vaʻai faʻamatala.
  59. Timmers, S., Konings, E., Bilet, L., Houtkooper, RH, van de Weijer, T., Goossens, GH, Hoeks, J., van der Krieken, S., Ryu, D., Kersten, S ., Moonen-Kornips, E., Hesselink, MK, Kunz, I., Schrauwen-Hinderling, VB, Blaak, EE, Auwerx, J., ma Schrauwen, P. Faʻatapulaʻaina o kalori i le 30 aso o le resveratrol faʻaopoopoga i malosi metabolism ma metabolic tala faʻasolopito i tagata puta tele. Cell Metab 11-2-2011; 14: 612-622. Vaʻai faʻamatala.
  60. Xuzhu, G., Komai-Koma, M., Leung, B. P., Howe, H. S., McSharry, C., McInnes, I. B., ma Xu, D. Resveratrol fesuiaʻi murine collagen-faʻaosoina gugu e ala i le taofiofia Th17 ma B-sela gaioiga. Ann.Rheum.Dis 2012; 71: 129-135. Vaʻai faʻamatala.
  61. Knight, CM, Gutierrez-Juarez, R., Lam, TK, Arrieta-Cruz, I., Huang, L., Schwartz, G., Barzilai, N., ma Rossetti, L. Mediobasal hypothalamic SIRT1 e taua mo resveratrol's aafiaga. i inisalini gaioiga i isumu. Maʻi suka 2011; 60: 2691-2700. Vaʻai faʻamatala.
  62. Howells, LM, Berry, DP, Elliott, PJ, Jacobson, EW, Hoffmann, E., Hegarty, B., Brown, K., Steward, WP, ma Gescher, AJ Phase I faʻasolosolo, faʻalua-tauaso pailate suʻesuʻega o micronized resveratrol (SRT501) i tagata mamaʻi ma hepatic metastases - saogalemu, vailaʻau ma vailaʻau, ma vailaʻau faʻasaina. Kanesa Prev. Rees (Phila) 2011; 4: 1419-1425. Vaʻai faʻamatala.
  63. Wuertz, K., Quero, L., Sekiguchi, M., Klawitter, M., Nerlich, A., Konno, S., Kikuchi, S., ma Boos, N. O le uaina mumu polyphenol resveratrol faʻaalia gafatia gafatia mo le togafiti o le fatu o le pulupus-faʻalauteleina tiga i vitro ma in vivo. Spine (Phila Pa 1976.) 10-1-2011; 36: E1373-E1384. Vaʻai faʻamatala.
  64. Brasnyo, P., Molnar, GA, Mohas, M., Marko, L., Laczy, B., Cseh, J., Mikolas, E., Szijarto, IA, Merei, A., Halmai, R., Meszaros, LG, Sumegi, B., ma Wittmann, I. Resveratrol faʻaleleia atili le lagona o le inisalini, faʻaititia le faʻamalosi o le oxidative ma faʻagaoioia le auala Akt i ituaiga 2 tagata mamaʻi suka. Br J Nutr. 2011; 106: 383-389. Vaʻai faʻamatala.
  65. Fabbrocini, G., Staibano, S., De, Rosa G., Battimiello, V., Fardella, N., Ilardi, G., La Rotonda, MI, Longobardi, A., Mazzella, M., Siano, M. , Pastore, F., De, Vita, V, Vecchione, ML, ma Ayala, F. Resveratrol-o loʻo i ai le gel mo le togafitia o fuafua i fafo: o le tasi-tauaso, taʻavale-faʻatonutonu, pailate suʻesuʻe. Am J Clin. Dermatol 4-1-2011; 12: 133-141. Vaʻai faʻamatala.
  66. Kitada, M., Kume, S., Imaizumi, N., ma Koya, D. Resveratrol faʻaleleia atili le faʻamalosia o le oxidative ma puipuia ai mai le suka suka nephropathy e ala i le faʻatulagaina masani o le Mn-SOD afaina i le AMPK / SIRT1-tutoʻatasi auala. Maʻi suka 2011; 60: 634-643. Vaʻai faʻamatala.
  67. Shindler, K. S., Ventura, E., Dutt, M., Elliott, P., Fitzgerald, D. C., ma Rostami, A. Oral resveratrol faʻaititia neuronal faʻaleagaina i se faʻataʻitaʻiga o le tele sclerosis. J Neuroophthalmol. 2010; 30: 328-339. Vaʻai faʻamatala.
  68. Brown, VA, Patel, KR, Viskaduraki, M., Crowell, JA, Perloff, M., Booth, TD, Vasilinin, G., Sen, A., Schinas, AM, Piccirilli, G., Brown, K., Steward, WP, Gescher, AJ, ma Brenner, DE Faʻaauau suʻesuʻega fualaʻau o le kanesa chemopreventive sooupu resveratrol i soifua maloloina volenitia: saogalemu, vailaʻau, ma aafiaga i le inisalini-pei tuputupu aʻe vaega. Kanesa Res 11-15-2010; 70: 9003-9011. Vaʻai faʻamatala.
  69. Patel, KR, Brown, VA, Jones, DJ, Britton, RG, Hemingway, D., Miller, AS, Sisifo, KP, Booth, TD, Perloff, M., Crowell, JA, Brenner, DE, Steward, WP, Gescher, AJ, ma Brown, K. Fomaʻi falemaʻi o resveratrol ma ona metabolites i colorectal kanesa gasegase. Kanesa Res 10-1-2010; 70: 7392-7399. Vaʻai faʻamatala.
  70. Knobloch, J., Sibbing, B., Jungck, D., Lin, Y., Urban, K., Stoelben, E., Strauch, J., ma Koch, A. Resveratrol faʻaleagaina le faʻasaʻolotoina o vailaʻau-teteʻe cytokines oona mai le tagata airway lamolemole maso sela i faʻamaʻi pipisi poloka poloka. J Pharmacol. Exp.Ther 2010; 335: 788-798. Vaʻai faʻamatala.
  71. Chow, HH, Garland, LL, Hsu, CH, Vining, DR, Chew, WM, Miller, JA, Perloff, M., Crowell, JA, ma Alberts, DS Resveratrol fesuiaʻi fualaʻau - ma le tino o le tino o le tino e fesoasoani i le soifua maloloina suesue. Kanesa Prev.Res (Phila) 2010; 3: 1168-1175. Vaʻai faʻamatala.
  72. Wong, R. H., Howe, P. R., Buckley, J. D., Coates, A. M., Kunz, I., ma Berry, N. M. Ogaoga resveratrol suplementation faaleleia tafe-faʻatulagaina dilatation i sili atu mamafa / obese tagata ma maualalo maualuga toto maualuga. Nutr.Metab Cardiovasc.Dis 2011; 21: 851-856. Vaʻai faʻamatala.
  73. la, Porte C., Voduc, N., Zhang, G., Seguin, I., Tardiff, D., Singhal, N., ma Cameron, DW Steady-State fale faʻamalositino ma faʻapalepaleina i le trans-resveratrol 2000 mg faʻalua i aso uma ma meaai, quercetin ma le ava malosi (ethanol) i soifua maloloina tagata mataupu. FalemaiFarmacokinet. 2010; 49: 449-454. Vaʻai faʻamatala.
  74. Le Couteur, D. G. ma Sinclair, D. A. O se mamanu mo le atiaʻeina o togafitiga togafitiga e faʻateleina ai le soifua maloloina ma faʻatuai ai le oti. J Gerontol.A Biol.Sci.Med Sci. 2010; 65: 693-694. Vaʻai faʻamatala.
  75. Kennedy, DO, Wightman, EL, Reay, JL, Lietz, G., Okello, EJ, Wilde, A., ma Haskell, CF Aafiaga o le resveratrol i luga o gasegase toto tafe fesuiaiga ma gaioiga gaioiga i tagata: a lua-tauaso, placebo -faʻatonutonu, suʻesuʻega o le crossover. Am J Clin.Nutr. 2010; 91: 1590-1597. Vaʻai faʻamatala.
  76. Daffner, K. R. Faʻalauiloaina le matua manuia o le mafaufau matua: o se auiliiliga iloiloina. J Alzheimers. Vaʻaia 2010; 19: 1101-1122. Vaʻai faʻamatala.
  77. Yu, H. P., Hwang, T. L., Hwang, T. L., Yen, C. H., ma Lau, Y. T. Resveratrol puipuia le faʻaleagaina o le endothelial ma le gaosiaina o le superoxide aortic pe a maeʻa le afaina o le toto e ala i le auala o le hemeoxygenase-1 auala o le receptor. Crit Care Med 2010; 38: 1147-1154. Vaʻai faʻamatala.
  78. Albani, D., Polito, L., ma Forloni, G. Sirtuins o ni fualaʻau fou mo le faʻamaʻi o le Alzheimer ma isi faʻaletonu o le neurodegenerative: faʻataʻitaʻiga ma faʻamaoniga faʻavae. J Alzheimers. Vaʻaia 2010; 19: 11-26. Vaʻai faʻamatala.
  79. Guo, J. P., Yu, S., ma McGeer, P. L. Faigofie i vitro suʻesuʻega e faʻailoa ai amyloid-beta faʻaputuputuina poloka mo Alzheimer's faamaʻi togafitiga. J Alzheimers. Faʻamatalaga. 2010; 19: 1359-1370. Vaʻai faʻamatala.
  80. Jha, R. K., Ma, Q., Sha, H., ma Palikhe, M. Puipuiga aafiaga o resveratrol i ogaoga pancreatitis-afaina ai faiai afaina. Pancreas 2009; 38: 947-953. Vaʻai faʻamatala.
  81. Zhang, H., Zhang, J., Ungvari, Z., ma Zhang, C. Resveratrol faaleleia endothelial gaioiga: matafaioi a TNF {alpha} ma vascular oxidative popole. Arterioscler.Thromb.Vasc.Biol. 2009; 29: 1164-1171. Vaʻai faʻamatala.
  82. Bournival, J., Quessy, P., ma Martinoli, M. G. Aafiaga puipuia o le resveratrol ma le quercetin faasaga i le MPP + -e faʻaosoina ai le faʻamalosi tino e ala i le faʻataʻitaʻia o faʻailoga o le oti apoptotic i dopaminergic neurons. Cell Mol.Neurobiol. 2009; 29: 1169-1180. Vaʻai faʻamatala.
  83. Almeida, L., Vaz-da-Silva, M., Falcao, A., Soares, E., Costa, R., Loureiro, AI, Fernandes-Lope, C., Rocha, JF, Nunes, T., Wright , L., ma Soares-da-Silva, P. Pharmacokinetic ma le saogalemu talaaga o trans-resveratrol i se faʻateleina tele-inumaga suʻesuʻega i soifua maloloina volenitia. Mol.Nutr.Food Res 2009; 53 Faʻaopopo 1: S7-15. Vaʻai faʻamatala.
  84. Vingtdeux, V., Dreses-Werringloer, U., Zhao, H., Davies, P., ma Marambaud, P. Therapeutic mafai o le resveratrol i le Alzheimer's disease. BMC.Neurosci. 2008; 9 Faʻamatalaga 2: S6. Vaʻai faʻamatala.
  85. Fan, E., Zhang, L., Jiang, S., ma Bai, Y. Aoga aoga o resveratrol i atherosclerosis. J Med Meaʻai 2008; 11: 610-614. Vaʻai faʻamatala.
  86. Vaz-da-Silva, M., Loureiro, AI, Falcao, A., Nunes, T., Rocha, JF, Fernandes-Lope, C., Soares, E., Wright, L., Almeida, L., ma Soares-da-Silva, P. Aʻafiaga o meaʻai i luga o le vailaʻau o vailaʻau o trans-resveratrol. Int.J Clin.Pharmacol.Ther 2008; 46: 564-570. Vaʻai faʻamatala.
  87. Dudley, J. I., Lekli, I., Mukherjee, S., Das, M., Bertelli, A. A., ma Das, D. K. E agavaʻa le uaina papaʻe i feteʻenaʻiga a Farani? Faʻatusatusaga o le cardioprotective aʻafiaga o mumu ma papaʻe uaina ma o latou sui: resveratrol, tyrosol, ma hydroxytyrosol. J Agric.Faia o Vailaʻau. 10-22-2008; 56: 9362-9373. Vaʻai faʻamatala.
  88. Orallo, F. Trans-resveratrol: o se faʻataulaitu o talavou e faavavau? Curr.Med Chem. 2008; 15: 1887-1898. Vaʻai faʻamatala.
  89. Rocha-Gonzalez, H. I., Ambriz-Tututi, M., ma Granados-Soto, V. Resveratrol: o se natura tuʻufaʻatasia ma vailaʻau faʻapitoa i faʻamaʻi neurodegenerative. CNS.Neurosci.Ther 2008; 14: 234-247. Vaʻai faʻamatala.
  90. Calabrese, V., Cornelius, C., Mancuso, C., Pennisi, G., Calafato, S., Bellia, F., Bates, TE, Giuffrida Stella, AM, Schapira, T., Dinkova Kostova, AT, ma Rizzarelli, E. Cellular stress response: o se taulaʻiga autu mo chemoprevention ma neuroprotection maloloina i le matua, neurodegenerative faaletonu ma longevity. Neurochem.Res 2008; 33: 2444-2471. Vaʻai faʻamatala.
  91. Pearson, KJ, Baur, JA, Lewis, KN, Peshkin, L., Tau, NL, Labinskyy, N., Swindell, WR, Kamara, D., Minor, RK, Perez, E., Jamieson, HA, Zhang, Y., Dunn, SR, Sharma, K., Pleshko, N., Woollett, LA, Csiszar, A., Ikeno, Y., Le Couteur, D., Elliott, PJ, Becker, KG, Navas, P., Ingram, DK, Wolf, NS, Ungvari, Z., Sinclair, DA, ma de Cabo, R. Resveratrol tolopo le matuaʻi faʻaletonu tausaga ma mimics transcriptal vaega o le faʻatapulaʻaina o meaʻai e aunoa ma le faʻalauteleina o le umi olaga. Cell Metab 2008; 8: 157-168. Vaʻai faʻamatala.
  92. Dong, W., Li, N., Gao, D., Zhen, H., Zhang, X., ma Li, F. Resveratrol faʻaleagaina ischemic faiai faʻaleagaina i le tuai tuai vaega ina ua maeʻa le stroke ma faʻatosina avefeʻau RNA ma porotini faʻaalia mo angiogenic itu. J Vasc.Surg. 2008; 48: 709-714. Vaʻai faʻamatala.
  93. Yu, H. P., Hsu, J. C., Hwang, T. L., Yen, C. H., ma Lau, Y. T. Resveratrol faʻafuaseia manua hepatic ina ua maeʻa trauma-hemorrhage ala ala i le estrogen receptor-auala auala. Faateʻia 2008; 30: 324-328. Vaʻai faʻamatala.
  94. Bass, T. M., Weinkove, D., Houthoofd, K., Gems, D., ma Partridge, L. Aafiaga o le resveratrol i le ola i Drosophila melanogaster ma Caenorhabditis elegans. Mech.Ageing Dev 2007; 128: 546-552. Vaʻai faʻamatala.
  95. Gruber, J., Tang, S. Y., ma Halliwell, B.Faʻamaoniga mo se fefaʻatauaiga i le va o le ola ma le malosi mafua mai i resveratrol togafitiga o Caenorhabditis elegans. Ann N Y.Acad Sci 2007; 1100: 530-542. Vaʻai faʻamatala.
  96. Baur, J. A. ma Sinclair, D. A. Therapeutic mafai o resveratrol: o le molimau mautinoa. Nat Rev Fualaʻau Discov. 2006; 5: 493-506. Vaʻai faʻamatala.
  97. Valenzano, D. R., Terzibasi, E., Genade, T., Cattaneo, A., Domenici, L., ma Cellerino, A. O le Resveratrol e faʻaumiumi le umi o le olaga ma faʻafuaseʻi ai le amataina o faʻailoga e faatatau i tausaga i se vertebrate puʻupuʻu. Curr Biol 2-7-2006; 16: 296-300. Vaʻai faʻamatala.
  98. Rakici, O., Kiziltepe, U., Coskun, B., Aslamaci, S., ma Akar, F. Aafiaga o le resveratrol i luga o leo leo ma endothelial gaioiga o le tagata saphenous uaua ma totonu mammary alatoto. Int.J Cardiol 11-2-2005; 105: 209-215. Vaʻai faʻamatala.
  99. Ma, Z. H. ma Ma, Q. Y. Resveratrol: o se vailaʻau vailaʻau mo matuitui pancreatitis. Lalolagi J Gastroenterol. 6-7-2005; 11: 3171-3174. Vaʻai faʻamatala.
  100. Molnar, V. ma Garai, J. Laʻau na maua mai i le tetee atu i le afaina o le toto ua aafia ai le gaioiga a le MIF tautomerase. Int.Immunopharmacol. 2005; 5: 849-856. Vaʻai faʻamatala.
  101. Provinciali, M., Re, F., Donnini, A., Orlando, F., Bartozzi, B., Di Stasio, G., ma Smorlesi, A. Aʻafiaga o le resveratrol i le atinaʻeina o le manava o le susu i HER-2 / neu transgenic isumu. Int.J Kanesa 5-20-2005; 115: 36-45. Vaʻai faʻamatala.
  102. Aggarwal, B. B., Bhardwaj, A., Aggarwal, R. S., Seeram, N. P., Shishodia, S., ma Takada, Y. Matafaioi o le resveratrol i le puipuia ma togafitiga o kanesa: preclinical ma falemaʻi suesuega. Anticancer Res. 2004; 24 (5A): 2783-2840. Vaʻai faʻamatala.
  103. Walle, T., Hsieh, F., DeLegge, M. H., Oatis, J. E., Jr., ma Walle, U. K. Maualuga faʻaaogaina ae o le maualalo tele o le bioavailability o le oral resveratrol i tagata. Fualaʻau Faʻasaina Metab. 2004; 32: 1377-1382. Vaʻai faʻamatala.
  104. Jannin, B., Menzel, M., Berlot, J. P., Delmas, D., Lancon, A., ma Latruffe, N. Felauaiga o le resveratrol, o le chemopreventive agents o le kanesa, i taulaʻiga tulimanu: fusia polotini fusiaina ma sela aveina. Biochem.Pharmacol. 9-15-2004; 68: 1113-1118. Vaʻai faʻamatala.
  105. Evers, D. L., Wang, X., Huong, S. M., Huang, D. Y., ma Huang, E. S. 3,4 ', 5-Trihydroxy-trans-stilbene (resveratrol) taofiofia ai le toe faia o le cytomegalovirus ma le faʻailoaina o siama sela. Antiviral Res. 2004; 63: 85-95. Vaʻai faʻamatala.
  106. Piver, B., Fer, M., Vitrac, X., Merillon, JM, Dreano, Y., Berthou, F., ma Lucas, D. Aofia ai o le cytochrome P450 1A2 i le biotransformation o trans-resveratrol i tagata ate microsome . Biochem.Pharmacol. 8-15-2004; 68: 773-782. Vaʻai faʻamatala.
  107. Wood, J. G., Rogina, B., Lavu, S., Howitz, K., Helfand, S. L., Tatar, M., ma Sinclair, D. Sirtuin activators mimic calric restric and tuai tuai i metazoans. Natura 8-5-2004; 430: 686-689. Vaʻai faʻamatala.
  108. Olas, B., Wachowicz, B., Bald, E., ma Glowacki, R. O aafiaga puipuia o le resveratrol faasaga i suiga i le toto platelet thiols na faʻatupuina e platinum compound. J.Physiol Pharmacol. 2004; 55: 467-476. Vaʻai faʻamatala.
  109. Cavallaro, A., Ainis, T., Bottari, C., ma Fimiani, V. Aʻafiaga o le resveratrol i nisi gaioiga o tuʻua ma i le toto atoa neutrophil tagata. Physiol Res. 2003; 52: 555-562. Vaʻai faʻamatala.
  110. Kim, YA, Lee, WH, Choi, TH, Rhee, SH, Park, KY, ma Choi, YH Faʻaaofia o p21WAF1 / CIP1, pRB, Bax ma NF-kappaB i le faʻatosinaina o le tuputupu aʻe o le puʻeina ma le apoptosis e le resveratrol i le kanesa o le tino kanesa Sela A549 Int.J.Oncol. 2003; 23: 1143-1149. Vaʻai faʻamatala.
  111. Howitz, KT, Bitterman, KJ, Cohen, HY, Lamming, DW, Lavu, S., Wood, JG, Zipkin, RE, Chung, P., Kisielewski, A., Zhang, LL, Scherer, B., ma Sinclair , DA Laʻititi mole mole faʻamalosia o sirtuins faʻalauteleina Saccharomyces cerevisiae olaga atoa. Natura 9-11-2003; 425: 191-196. Vaʻai faʻamatala.
  112. Delmas, D., Rebe, C., Lacour, S., Filomenko, R., Athias, A., Gambert, P., Cherkaoui-Malki, M., Jannin, B., Dubrez-Daloz, L., Latruffe , N., ma Solary, E. Resveratrol-faʻatosina apoptosis e fesoʻotaʻi ma Fas tufatufaina i totonu o vaʻa ma le fausiaina o se maliu-faʻamalosia faʻailo faigata i kolone kanesa sela. J.Biol.Chem. 10-17-2003; 278: 41482-41490. Vaʻai faʻamatala.
  113. Liang, Y. C., Tsai, S. H., Chen, L., Lin-Shiau, S. Y., ma Lin, J. K. Resveratrol-faatosina G2 pueina e ala i le taofiofia o CDK7 ma p34CDC2 kinases i kolone kanesa HT29 sela. Biochem.Pharmacol. 4-1-2003; 65: 1053-1060. Vaʻai faʻamatala.
  114. Klinge, C. M., Risinger, K. E., Watts, M. B., Beck, V., Eder, R., ma Jungbauer, A. Estrogenic gaioiga i papaʻe ma mumu uaina vaega. J Agric.Food Chem 3-26-2003; 51: 1850-1857. Vaʻai faʻamatala.
  115. Vitrac, X., Desmouliere, A., Brouillaud, B., Krisa, S., Deffieux, G., Barthe, N., Rosenbaum, J., ma Merillon, JM Tufatufaina o [14C] -trans-resveratrol, a kanesa chemopreventive polyphenol, i isumu iʻa ina ua uma tuufofoga pulega. Olaga Sci 4-4-2003; 72: 2219-2233. Vaʻai faʻamatala.
  116. Levenson, AS, Gehm, BD, Pearce, ST, Horiguchi, J., Simons, LA, Ward, JE, III, Jameson, JL, ma Jordan, VC Resveratrol galue o se estrogen receptor (ER) agonist i susu kanesa sela mausali fesuiaʻi ma ER alpha. Int.J. Kanesa 5-1-2003; 104: 587-596. Vaʻai faʻamatala.
  117. Yu, C., Shin, Y. G., Kosmeder, J. W., Pezzuto, J. M., ma van Breemen, R. B. Liquid chromatography / tandem mass spectrometric fuafuaina o le taofiofia o tagata cytochrome P450 isozymes e le resveratrol ma resveratrol-3-sulfate. Rapid Commun.Mass Spectrom. 2003; 17: 307-313. Vaʻai faʻamatala.
  118. Olas, B., Wachowicz, B., Saluk-Juszczak, J., ma Zielinski, T. Aafiaga o le resveratrol, o se natura polyphenolic compound, i luga o le platelet activation na mafua mai i le endotoxin poʻo le thrombin. Luga.Res 8-15-2002; 107 (3-4): 141-145. Vaʻai faʻamatala.
  119. Wallerath, T., Deckert, G., Ternes, T., Anderson, H., Li, H., Witte, K., ma Forstermann, U. Resveratrol, o se polyphenolic phytoalexin o loʻo i ai i le uaina mumu, faʻalauteleina le faʻaalia ma gaioiga a endothelial nitric oxide synthase. Faasalalauina 9-24-2002; 106: 1652-1658. Vaʻai faʻamatala.
  120. Sharma, M. ma Gupta, Y. K. Faʻataʻitaʻi togafitiga ma trans resveratrol puipuia intracerebroventricular streptozotocin faʻatosina le mafaufau faʻaleagaina ma oxidative atuatuvale i isumu. Olaga Sci 10-11-2002; 71: 2489-2498. Vaʻai faʻamatala.
  121. Holian, O., Wahid, S., Atten, M. J., ma Attar, B. M. Faʻalavelaveina o le kanesa o le gastric sela faʻateleina e resveratrol: matafaioi a nitric oxide. Am.J.Physiol Gastrointest.Liver Physiol 2002; 282: G809-G816. Vaʻai faʻamatala.
  122. Potter, GA, Patterson, LH, Wanogho, E., Perry, PJ, Butler, PC, Ijaz, T., Ruparelia, KC, Lamb, JH, Farmer, PB, Stanley, LA, ma Burke, MD O le kanesa puipuia vailaʻau resveratrol ua liua i le anticancer sooupu piceatannol e le cytochrome P450 enzyme CYP1B1. Br.J. Kanesa 3-4-2002; 86: 774-778. Vaʻai faʻamatala.
  123. Falchetti, R., Fuggetta, M. P., Lanzilli, G., Tricarico, M., ma Ravagnan, G. Aafiaga o le resveratrol i le tagata puipuia sela sela gaioiga. Olaga Sci. 11-21-2001; 70: 81-96. Vaʻai faʻamatala.
  124. Bhavnani, BR, Cecutti, A., Gerulath, A., Woolever, AC, ma Berco, M. Faʻatusatusaga o aafiaga o le antioxidant o equine estrogens, mumu vaega o le uaina, vaitamini E, ma le probucol luga maualalo-maualuga lipoprotein okesene i fafine postmenopausal . Maloloaga 2001; 8: 408-419. Vaʻai faʻamatala.
  125. Bhat, K. P., Lantvit, D., Christov, K., Mehta, R. G., Moon, R. C., ma Pezzuto, J. M. Estrogenic ma antiestrogenic meatotino o le resveratrol i mammary tumo models. Kanesa Res. 10-15-2001; 61: 7456-7463. Vaʻai faʻamatala.
  126. Lee, J. E. ma Safe, S. Faʻaaofiaina o se post-transcriptional auala i le taofiofia o le CYP1A1 faʻaalia e le resveratrol i susu kanesa sela. Biochem.Pharmacol. 10-15-2001; 62: 1113-1124. Vaʻai faʻamatala.
  127. Bhat, K. P. ma Pezzuto, J. M. Resveratrol o loʻo faʻaalia ai mea totino o le cytostatic ma le antiestrogenic ma sela o le endometrial adenocarcinoma (Ishikawa). Kanesa Res. 8-15-2001; 61: 6137-6144. Vaʻai faʻamatala.
  128. Nicolini, G., Rigolio, R., Miloso, M., Bertelli, A. A., ma Tredici, G. Aneti-apoptotic aafiaga o trans-resveratrol luga paclitaxel-faʻaosoina apoptosis i le tagata neuroblastoma SH-SY5Y sela laina. Neurosci.Lett. 4-13-2001; 302: 41-44. Vaʻai faʻamatala.
  129. Giovannini, L., Migliori, M., Longoni, BM, Das, DK, Bertelli, AA, Panichi, V., Filopio, C., ma Bertelli, A. Resveratrol, o se polyphenol maua i le uaina, faʻaititia ischemia reperfusion manuʻa i fatugaʻo isumu. J Cardiovasc.Farmacol. 2001; 37: 262-270. Vaʻai faʻamatala.
  130. Chan, W. K. ma Delucchi, A. B. Resveratrol, o se mea inu uaina mumu, o se masini-faʻavae inactivator o cytochrome P450 3A4. Olaga Sci 11-10-2000; 67: 3103-3112. Vaʻai faʻamatala.
  131. Wang, M. J., Huang, H. M., Hsieh, S. J., Jeng, K. C., ma Kuo, J. S. Resveratrol taofiofia interleukin-6 gaosiga i totonu o le sela fefiloi sela i lalo o le hypoxia / hypoglycemia sosoo ai ma le reoxygenation. J Neuroimmunol. 1-1-2001; 112 (1-2): 28-34. Vaʻai faʻamatala.
  132. Chang, T. K., Lee, W. B., ma Ko, H. H. Trans-resveratrol fesuiaʻi le gaioiga gaioiga ma mRNA faʻaaliga o le procarcinogen-faʻagaoioia tagata cytochrome P450 1B1. Can.J.Physiol Pharmacol. 2000; 78: 874-881. Vaʻai faʻamatala.
  133. Burkitt, M. J. ma Duncan, J. Aafiaga o trans-resveratrol i luga o le kopa-faʻalagolago hydroxyl-radical faʻavaeina ma DNA faʻaleagaina: faʻamaoniga mo hydroxyl-radical scavenging ma se tala, glutathione-faasaoina auala o gaioiga. Faʻaputuga 9-15-2000; 381: 253-263. Vaʻai faʻamatala.
  134. Zbikowska, H. M. ma Olas, B. Antioxidants ma le gaioiga o le tino (resveratrol, vitamini E ma le selenium) i le faʻatupuina o le toto faʻamaʻa pipisi. J Physiol Pharmacol. 2000; 51: 513-520. Vaʻai faʻamatala.
  135. Kirk, R. I., Deitch, J. A., Wu, J. M., ma Lerea, K. M. Resveratrol na faʻaititia vave faʻailogaina gaioiga i fufuluina peleti ae leai se aʻafiaga i platalet i meaai atoa. Toto sela Mol. 2000; 26: 144-150. Vaʻai faʻamatala.
  136. Bagchi, D., Bagchi, M., Stohs, S. J., Das, D. K., Ray, S. D., Kuszynski, C. A., Joshi, S. S., ma Pruess, H. G. Free radicals and grape seed proanthocyanidin extract: taua i le soifua maloloina o tagata ma faʻamaʻi puipuiga. Toxicology 8-7-2000; 148 (2-3): 187-197. Vaʻai faʻamatala.
  137. Bradamante, S., Piccinini, F., Barenghi, L., Bertelli, A. A., De Jonge, R., Beemster, P., ma De Jong, J. W. E faʻaosoina e le resveratrol le faʻataʻitaʻiga o vailaʻau? Int.J Tissue Tali. 2000; 22: 1-4. Vaʻai faʻamatala.
  138. Naderali, E. K., Doyle, P. J., ma Williams, G. Resveratrol faʻaosoina vasorelaxation o mesenteric ma uterine alatoto mai fafine guinea-puaa. Clin sci (Lond) 2000; 98: 537-543. Vaʻai faʻamatala.
  139. Klabunde, T., Petrassi, H. M., Oza, V. B., Raman, P., Kelly, J. W., ma Sacchettini, J. C. Faʻatulagaina lelei o le malosi o le tagata transthyretin amyloid faamaʻi faʻamaʻi. Nat Struct.Biol. 2000; 7: 312-321. Vaʻai faʻamatala.
  140. Martinez, J. ma Moreno, J. J. Aʻafiaga o resveratrol, o se natura polyphenolic compound, i le toe ola okesene ituaiga ma prostaglandin gaosiga. Biochem.Pharmacol 4-1-2000; 59: 865-870. Vaʻai faʻamatala.
  141. Subbaramaiah, K., Michaluart, P., Chung, W. J., Tanabe, T., Telang, N., ma Dannenberg, A. J. Resveratrol taofia le cyclooxygenase-2 transcription i tagata mammary epithelial sela. Ann.NYY.Acad.Sci. 1999; 889: 214-223. Vaʻai faʻamatala.
  142. Dobrydneva, Y., Williams, R. L., ma Blackmore, P. F. trans-Resveratrol taofia le lolovaia kalisiu i thrombin-faaosofia tagata lapisi. Br.J.Farmacol. 1999; 128: 149-157. Vaʻai faʻamatala.
  143. Ciolino, H. P. ma Yeh, G. C. Faʻalavelaveina o le aryl hydrocarbon-induced cytochrome P-450 1A1 enzyme gaoioiga ma le CYP1A1 faʻaali e resveratrol. Mol.Pharmacol. 1999; 56: 760-767. Vaʻai faʻamatala.
  144. Lin, J. K. ma Tsai, S. H. Chemoprevention o kanesa ma faʻamaʻi fatu fatu e resveratrol. Proc.Natl.Sci.Counc.Repub.China B 1999; 23: 99-106. Vaʻai faʻamatala.
  145. Zou, J. G., Huang, Y. Z., Chen, Q., Wei, E. H., Hsieh, T. C., ma Wu, J. M. Resveratrol taofia le apamemea ion-faaosofia ma azo tuufaatasi-amataina oxidative fesuiaiga o le maualalo maualuga density lipoprotein. Biochem.Mol.Biol.Int. 1999; 47: 1089-1096. Vaʻai faʻamatala.
  146. Rahman, I. Antioxidant togafitiga muamua i COPD. Ther.Adv.Respir.Dis. 2008; 2: 351-374. Vaʻai faʻamatala.
  147. Kimura, Y., Okuda, H., ma Kubo, M. Aʻafiaga o stilbenes vavae ese mai vailaʻau laʻau i luga o le arachidonate metabolism ma le faʻaleagaina o le tagata polymorphonuclear leukocytes. J Ethnopharmacol. 1995; 45: 131-139. Vaʻai faʻamatala.
  148. Tome-Carneiro, J., Gonzalvez, M., Larrosa, M., Garcia-Almagro, FJ, Aviles-Plaza, F., Parra, S., Yanez-Gascon, MJ, Ruiz-Ros, JA, Garcia-Conesa , MT, Tomas-Barberan, FA, ma Espin, JC O le faʻaaogaina o se fualaʻau aina o loʻo i ai le resveratrol e faʻaititia ai le LDL ma ApoB o loʻo gasegase i le puipuia muamua o faʻamaʻi fatu; , faʻamasinoga faʻapitoa. Mol.Nutr Meaʻai Res 2012; 56: 810-821. Vaʻai faʻamatala.
  149. Tome-Carneiro, J., Gonzalvez, M., Larrosa, M., Yanez-Gascon, MJ, Garcia-Almagro, FJ, Ruiz-Ros, JA, Garcia-Conesa, MT, Tomas-Barberan, FA, ma Espin, JC Tasi le tausaga taumafaina o se fualaʻau maloloina fualaʻau o loʻo iai resveratrol faʻaleleia le fefete ma fibrinolytic tulaga o tagata mamaʻi i muamua puipuia o faʻamaʻi fatu Am J Cardiol. 8-1-2012; 110: 356-363. Vaʻai faʻamatala.
  150. Zern, TL, Wood, RJ, Greene, C., West, KL, Liu, Y., Aggarwal, D., Shachter, NS, ma Fernandez, ML Grape polyphenols o loʻo faia se aafiaga o le cardioprotective i fafine muamua ma le faʻamavae e ala i le tuʻuina ifo o le plasma lipids ma faʻaititia le faʻamama o le oxidative J Nutr. 2005; 135: 1911-1917. Vaʻai faʻamatala.
  151. Piver, B., Berthou, F., Dreano, Y., ma Lucas, D. Eseesega taofiofia o tagata cytochrome P450 enzymes e epsilon-viniferin, o le vaivai o le resveratrol: faʻatusatusaga ma resveratrol ma polyphenols mai meainu faʻamalosi. Olaga Sci. 7-18-2003; 73: 1199-1213. Vaʻai faʻamatala.
  152. de, Santi C., Pietrabissa, A., Mosca, F., ma le Pacifici, G. M. Glucuronidation o le resveratrol, o se oloa masani o loʻo i ai i le vine ma le uaina, i le ate o le tagata. Xenobiotica 2000; 30: 1047-1054. Vaʻai faʻamatala.
  153. Rosa, F. T., Zulet, M. A., Marchini, J. S., ma Martinez, J. A. O vailaʻau o loʻo i ai vailaʻau ma aʻafiaga o le pupuga o tagata. Int J Food Sci Nutr 2012; 63: 749-765. Vaʻai faʻamatala.
  154. Chang, T. K., Chen, J., ma Lee, W. B. Eseese taofi ma le le toe faʻagaoioia o tagata CYP1 enzymes e trans-resveratrol: faʻamaoniga mo le faʻaaogaina-faʻavae masini o CYP1A2. J.Pharmacol.Exp.Ther. 2001; 299: 874-882. Vaʻai faʻamatala.
  155. Basly, J. P., Marre-Fournier, F., Le Bail, J. C., Habrioux, G., ma Chulia, A. J. Estrogenic / antiestrogenic ma scavenging meatotino o (E) - ma (Z) -resveratrol. Olaga Sci. 1-21-2000; 66: 769-777. Vaʻai faʻamatala.
  156. Mueller SO, Simon S, Chae K, et al. Phytoestrogens ma a latou tagata metabolites faʻaalia eseese agonistic ma antagonistic meatotino luga estrogen receptor alpha (ERalpha) ma ERbeta i tagata sela. Toxicol Sci 2004; 80: 14-25. Vaʻai faʻamatala.
  157. Boocock DJ, Faust GE, Patel KR, et al. Vaega I fualaʻau faʻateleina vailaʻau faʻaleaʻoaʻoga i le soifua maloloina volenitia o resveratrol, o le ono kanesa chemopreventive sooupu. Kanesa Epidemiol Biomarkers Prev 2007; 16: 1246-52. Vaʻai faʻamatala.
  158. Lyons MM, Yu C, Toma RB, et al. Resveratrol i fualaʻau mata ma vela fugalaʻau ma bilberry. Le J Agric Food Chem 2003; 51: 5867-70. Vaʻai faʻamatala.
  159. Trincheri NF, Nicotra G, Follo C, et al. Resveratrol mafua ai le oti o sela i sela o le kanesa colorectal e ala fou e aofia ai lysosomal cathepsin D. Carcinogenesis 2007; 28: 922-31. Vaʻai faʻamatala.
  160. Scarlatti F, Sala G, Somenzi G, et al. Resveratrol faʻamalosia le tuputupu ae taofiofia ma apoptosis i metastatic susu kanesa sela e ala de novo ceramide faʻailo. FASEB J 2003; 17: 2339-41. Vaʻai faʻamatala.
  161. Wang Q, Li H, Wang XW, et al. Resveratrol faʻalauteleina le faʻaeseesega ma faʻamalosia Fas-tutoʻatasi apoptosis o tagata medulloblastoma sela. Neurosci Lett 2003; 351: 83-6. Vaʻai faʻamatala.
  162. Culpitt SV, Rogers DF, Fenwick PS, et al. Faʻatamaia e le mumu uaina vaega, resveratrol, o le cytokine faʻasaʻolotoina e alveolar macrophages i le COPD. Thorax 2003; 58: 942-6. Vaʻai faʻamatala.
  163. Pervaiz S. Resveratrol: mai le vine i mammalian biology. FASEB J 2003; 17: 1975-85. Vaʻai faʻamatala.
  164. Savaskan E, Olivieri G, Meier F, et al. Ua puipuia e le uaina mumu le resveratrol mai le beta-amyloid neurotoxicity. Gerontology 2003; 49: 380-3. Vaʻai faʻamatala.
  165. Gao X, Deeb D, Media J, et al. Gaioiga puipuia o resveratrol: feeseeseaiga i vitro ma i vivo aafiaga puipuia. Biochem Pharmacol 2003; 66: 2427-35. Vaʻai faʻamatala.
  166. Schriever C, Pendland SL, Mahady GB. Uaina mumu, resveratrol, Chlamydia pneumoniae ma le Farani sootaga. Atherosclerosis 2003; 171: 379-80. Vaʻai faʻamatala.
  167. Ziegler CC, Rainwater L, Whelan J, McEntee MF. O meaʻai e faʻatatau i le resveratrol e le afaina ai le tumigenesis i totonu ole isumu Apc (Min / +). J Nutr 2004; 134: 5-10. Vaʻai faʻamatala.
  168. Kim YA, Choi BT, Lee YT, et al. Resveratrol taofia le faʻateleina o sela ma faʻaosofia apoptosis o tagata susu susu kanesa MCF-7 sela. Oncol Rep 2004; 11: 441-6. Vaʻai faʻamatala.
  169. Zhang Y, Jayaprakasam B, Seeram NP, et al. Insulin secretion ma cyclooxygenase enzyme taofi e cabernet sauvignon vine fua paʻu. Le J Agric Food Chem 2004; 52: 228-33. Vaʻai faʻamatala.
  170. Opipari AW Jr, Tan L, Boitano AE, et al. Resveratrol-faʻaosoina autophagocytosis i sela o le kanesa ovarian. Kanesa Res 2004; 64: 696-703. Vaʻai faʻamatala.
  171. Abou-Zeid LA, El-Mowafy AM. Eseesega iloa o resveratrol isomers e le tagata estrogen receptor-alpha: molemole dynamics faamaoniga mo stereoselective ligand fusifusia. Chirality 2004; 16: 190-5. Vaʻai faʻamatala.
  172. Meng X, Maliakal P, Lu H, et al. O le urinary ma le plasma tulaga o le resveratrol ma le quercetin i tagata, isumu, ma isumu ina ua uma ona taumafaina i totonu o le mama vaega ma sua o le vine. Le J Agric Food Chem 2004; 52: 935-42. Vaʻai faʻamatala.
  173. Hascalik S, Celik O, Turkoz Y, et al. Resveratrol, o le mumu uaina constituent polyphenol, puipuia mai ischemia-reperfusion faʻaleagaina o ovaries. Gynecol Obstet Invest 2004; 57: 218-23. Vaʻai faʻamatala.
  174. Ahmad KA, Clement MV, Hanif IM, Pervaiz S. Resveratrol taofia le apoptosis faʻatosina fualaʻau i sela o leukemia tagata e ala i le fausiaina o se intracellular milieu le faʻamalosia mo le oti faʻasalaga. Kanesa Res 2004; 64: 1452-9. Vaʻai faʻamatala.
  175. Li W, Seifert M, Xu Y, Hock B. Faʻatusatusaga suʻesuʻega o le estrogenic malosiaga o estradiol, tamoxifen, bisphenol-A ma resveratrol ma lua i vitro bioassay. Environ Int 2004; 30: 329-35. Vaʻai faʻamatala.
  176. Martin AR, Villegas I, La Casa C, de la Lastra CA. Resveratrol, o se polyphenol o loʻo maua i vine, e taofiofia ai le faʻaleagaina o le oxidative ma faʻaosofia ai le apoptosis i le amataga o le colonic fulafula i isumu. Biochem Pharmacol 2004; 67: 1399-410. Vaʻai faʻamatala.
  177. Szewczuk LM, Forti L, Stivala LA, Penning TM.Resveratrol o se peroxidase faʻatonutonu inactivator o COX-1 ae le o le COX-2: O se faʻatatauga auala i le mamanu o COX-1 filifilia sui. J Biol Chem 2004; 279: 22727-37. Vaʻai faʻamatala.
  178. Wang Z, Huang Y, Zou J, et al. Aafiaga o le uaina mumu ma le uaina polyphenol resveratrol luga o lapisi faʻaputuputu i vivo ma in vitro. Int J Mol Med 2002; 9: 77-9. Vaʻai faʻamatala.
  179. Mokni M, Limam F, Elkahoui S, et al. Malosiaga o le cardioprotective aafiaga o le resveratrol, o le uaina mumu polyphenol, i le tuʻimomomoina o rat peʻa o le ischemia / reperfusion manuʻa. Arch Biochem Biophys 2007; 457: 1-6. Vaʻai faʻamatala.
  180. Elmali N, Baysal O, Harma A, et al. Aʻafiaga o resveratrol i mumusu gugu. Faʻafitauli 2007; 30: 1-6. Vaʻai faʻamatala.
  181. Bujanda L, Garcia-Barcina M, Gutierrez-de Juan V, et al. Aʻafiaga o le resveratrol i le ava malosi-faʻatupuina le oti ma le ate papala i isumu. BMC Gastroenterol 2006; 6:35. Vaʻai faʻamatala.
  182. Baur JA, Pearson KJ, Tau NL, et al. Resveratrol faʻaleleia le soifua maloloina ma le ola o isumu i luga o le maualuga-kalori taumafataga. Natura 2006; 444: 337-42. Vaʻai faʻamatala.
  183. Murias M, Handler N, Erker T, et al. Resveratrol analogues pei filifilia cyclooxygenase-2 inhibitors: synthes ma fausaga-gaioiga sootaga. Bioorg Med Chem 2004; 12: 5571-8. Vaʻai faʻamatala.
  184. Hwang D, Fischer NH, Jang BC, et al. O le taofiofia o le faʻaaliga o le gasegase o le cyclooxygenase ma le cyinfine e faʻatupuina e le sesquiterpene lactones i macrophages e fesoʻotaʻi ma le taofiofia o le MAP kinases. Biochem Biophys Res Commun 1996; 226: 810-8 .. Seʻi vaʻaia.
  185. Takada Y, Bhardwaj A, Potdar P, Aggarwal BB. Nonsteroidal anti-inflammatory agents e eseʻese i lo latou agavaʻa e taofi le faʻagaoioia o le NF-kappaB, taofia o le faʻaalia o le cyclooxygenase-2 ma le cyclin D1, ma le faʻaleaogaina o le faʻatupulaia o sela sela. Oncogene 2004; 23: 9247-58. Vaʻai faʻamatala.
  186. Goldberg DM, Yan J, Soleas GJ. Faʻatagaina o le tolu uaina-fesoʻotaʻi polyphenols i le tolu matrices eseese e maloloina mataupu. Clin Biochem 2003; 36: 79-87 .. Vaʻaia faʻavaʻa.
  187. Docherty JJ, Fu MM, Stiffler BS, et al. Resveratrol taofiofia o le herpes simplex siama faʻafouina. Antiviral Res 1999; 43: 145-55. Vaʻai faʻamatala.
  188. Bowers JL, Tyulmenkov VV, Jernigan SC, Klinge CM. Resveratrol galue o se fefiloi agonist / antagonist mo estrogen mauaina alpha ma beta. Endocrinology 2000; 141: 3657-67.
  189. Piver B, Berthou F, Dreano Y, Lucas D. Faʻalavelaveina o CYP3A, CYP1A ma CYP2E1 gaioiga e resveratrol ma isi e le mumu suia uaina vaega. Toxicol Lett 2001; 125: 83-91. Vaʻai faʻamatala.
  190. Laden BP, Porter TD. Resveratrol taofia le tagata squalene monooxygenase. Nutr Res 2001; 21: 747-53.
  191. Kozuki Y, Miura Y, Yagasaki K. Resveratrol taofia le osofaʻiga o le sela o le hepatoma tutoatasi mai lana gaioiga tetee-faʻateleina. Kanesa Lett 2001; 167: 151-6. Vaʻai faʻamatala.
  192. Schneider Y, Vincent F, Duranton B, et al. Aneti-faʻalauteleina aafiaga o resveratrol, o se natura vaega o vine ma le uaina, i tagata colonic kanesa sela. Kanesa Lett 2000; 158: 85-91.
  193. Jacobson JS, Troxel AB, Evans J, et al. Le faʻataʻitaʻiga faʻataʻitaʻi o le uliuli cohosh mo le togafitia o vevela susulu i totonu o fafine ma le talaʻaga o le kanesa o le susu. J Clin Oncol 2001; 19: 2739-45. Vaʻai faʻamatala.
  194. Holmes-McNary M, Baldwin AS, Jr Chemopreventive meatotino o trans-resveratrol e fesoʻotaʻi ma le taofiofia o le faʻagaioiga o le IkappaB kinase. Kanesa Res 2000; 60: 3477-83. Vaʻai faʻamatala.
  195. Bertelli AA, Giovannini L, Giannessi D, et al. Antiplatelet gaioiga o gaosi ma masani resveratrol i mumu uaina. Int J Tissue Tali 1995; 17: 1-3. Vaʻai faʻamatala.
  196. Gehm BD, McAndrews JM, Chien PY, Jameson JL. Resveratrol, o se polyphenolic compound o loʻo maua i grapes ma le uaina, o se agonist mo le estrogen receptor. Faʻataʻitaʻiga Natl Acad Sci U S A 1997; 94: 14138-43. Vaʻai faʻamatala.
  197. Carbo N, Costelli P, Baccino FM, et al. Resveratrol, o se oloa masani o loʻo i ai i le uaina, faʻaititia ai le tuputupu aʻe o le maʻi o le rat. Biochem Biophys Res Commun 1999; 254: 739-43. Vaʻai faʻamatala.
  198. Huang C, Ma WY, Goranson A, Dong Z. Resveratrol taofia le suiga o sela ma faʻamalosia le apoptosis e ala i le p53-faʻamoemoe auala. Carcinogenesis 1999; 20: 237-42. Vaʻai faʻamatala.
  199. Davy BM, Melby CL, Beske SD, et al. Oat taumafa e le afaina ai le malolo faʻamalieina ma faʻamalosi 24-h toto toto toto i alii ma maualuga-masani toto maualuga i le tulaga ou toto maualuga. J Nutr 2002; 132: 394-8 .. Seʻi vaʻaia.
  200. Chen CK, Pace-Asciak CR. Vasorelaxing gaoioiga o resveratrol ma quercetin i tuʻimomomo rat aorta. Gen Pharmacol 1996; 27: 363-6. Vaʻai faʻamatala.
  201. Bertelli A, Bertelli AA, Gozzini A, Giovannini L. Plasma ma le tino resveratrol concentrations ma vailaʻau gaioiga. Fualaʻau Exp Clin Res 1998; 24: 133-8. Vaʻai faʻamatala.
  202. Pace-Asciak CR, Hahn S, Diamandis EP, et al. O le mumu uaina phenolics trans-resveratrol ma quercetin poloka tagata platelet faʻaputuputuina ma eicosanoid synthes: aʻafiaga mo le puipuiga mai coronary fatu faʻamaʻi. Clin Chim Acta 1995; 235: 207-19. Vaʻai faʻamatala.
  203. Bertelli AA, Giovannini L, Bernini W, et al. Antiplatelet gaioiga o cis-resveratrol. Fualaʻau Exp Clin Res 1996; 22: 61-3. Vaʻai faʻamatala.
  204. Pace-Asciak CR, Rounova O, Hahn SE, et al. Uaina ma sua o sua e fai ma faʻataʻitaʻiga o le faʻaputuputuina o le lapisi i tagata soifua maloloina mataupu. Clin Chim Acta 1996; 246: 163-82. Vaʻai faʻamatala.
  205. Jang M, Cai L, Udeani GO, et al. Gaioiga chemopreventive gaioiga o resveratrol, o se natura oloa maua mai fua. Saienisi 1997; 275: 218-20. Vaʻai faʻamatala.
  206. Soleas GJ, Diamandis EP, Goldberg DM. Resveratrol: o se molemole o lona taimi ua oʻo mai? Ma ua alu? Clin Biochem 1997; 30: 91-113. Vaʻai faʻamatala.
  207. Agri Res Svc: Dr. Duke's phytochemical ma etnobotanical database. www.ars-grin.gov/duke (Avanoa i le 3 Novema 1999).
  208. Le iloiloga o Natura Oloa e Mea Moni ma Faʻatusatusaga. St.Louis, MO: Wolters Kluwer Co., 1999.
  209. Foster S, Tyler VE. Tyler's Honest Herbal: O Se Faʻatonuga Mautinoa i le Faʻaaogaina o Laʻau ma Faʻafofoaga Fesoʻotaʻi. 3rd ed., Binghamton, NY: Haworth Herbal Press, 1993.
  210. Newall CA, Anderson LA, Philpson JD. Vailaau Faʻamaloloina: O Se Taʻiala mo Tomai Faʻapitoa mo le Soifua Maloloina. Lonetona, Peretania: Le Fale Talavai, 1996.
  211. Tyler VE Laʻau o Filifiliga. Binghamton, NY: Fale Talavai Oloa, 1994.
  212. Blumenthal M, ed. Le Atoa Siamani Komisi E Monographs: Therapeutic Guide to Herbal Medicines. Trans. S. Klein. Boston, MA: American Botanical Council, 1998.
  213. Monograps i luga o vailaʻau faʻaaogaina o laʻau fualaʻau. Exeter, UK: European Scientific Co-op Phytother, 1997.
Toe iloiloga - 09/30/2020

Tatalaina Lomiga Fou

Mai le Metabolism i le LSD: 7 Tagata Suʻesuʻe Na Faʻataʻitaʻi ia Latou Lava
Soifua Maloloina

Mai le Metabolism i le LSD: 7 Tagata Suʻesuʻe Na Faʻataʻitaʻi ia Latou Lava

Faata i ai ma le ofoofogia o a o nei vailaʻau, e faigofie ona faagalo o le tele o ia a leʻi iloaina. O le mea moni, o i i togafitiga faʻafomaʻi ili ili i a o nei (pei o vaʻaigala) ma faʻagaioiga o le ...
Faʻailoga o le Celiac Disease, Wheat Allergy, ma le Non-Celiac Gluten Sensitivity: O Fea?
Soifua Maloloina

Faʻailoga o le Celiac Disease, Wheat Allergy, ma le Non-Celiac Gluten Sensitivity: O Fea?

Tele o tagata e maua ile faʻafitauli o le dige tive ma le oifua maloloina e mafua mai ile 'ai o le kuli i poʻo le aito. Afai o oe poʻo lau tama o loʻo feagai ma le le faʻapalepaleina i le kulukeni...